Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TAI Diagnostics

TAI Diagnostics?uq=UG6efJS6
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$12.8M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a non-invasive and highly sensitive diagnostic test designed to monitor the health of transplanted organs. The company's proprietary non-invasive assay which utilizes cf-DNA technology as a direct measurement of organ injury through quantitation of donor-specific cf-DNA released into the bloodstream from injured cells of a transplanted organ, enabling physicians to detect rejection early and perform surveillance biopsies at regular intervals caused by a deletion from chromosome 22 at the q11 location.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • 10101 Innovation Drive
  • Suite 600
  • Milwaukee, WI 53226
  • United States

+1 (414) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TAI Diagnostics’s full profile, request a free trial.

TAI Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 08-Jan-2018 $12.8M 000.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 23-Oct-2015 00.00 00.00 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

TAI Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

TAI Diagnostics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
United Therapeutics Corporation Minority 000 0000 000000 0
Venture Investors Venture Capital Minority 000 0000 000000 0
Wisconsin Economic Development Corporation Lender/Debt Provider Minority 000 0000 000000 0

TAI Diagnostics Executive Team (2)

Name Title Board
Seat
Contact
Info
Frank Langley Chief Executive Officer & Board Member
Aoy Tomita-Mitchel Ph.D Co-Founder, Board Director & Chief Scientific Officer

TAI Diagnostics Board Members (5)

Name Representing Role Since Contact
Info
Aoy Tomita-Mitchel Ph.D TAI Diagnostics Co-Founder, Board Director & Chief Scientific Officer 000 0000
Frank Langley TAI Diagnostics Chief Executive Officer & Board Member 000 0000
John Fowler Self Board Member 000 0000
John Neis Venture Investors Board Member 000 0000
Michael Mitchell MD Self Co-Founder, Chief Clinical Advisor & Board Member 000 0000